Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580

Patrick A. Eyers, Paul Van Den Ijssel, Roy A. Quinlan, Michel Goedert, Philip Cohen (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    96 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580'. Together they form a unique fingerprint.

    Chemical Compounds

    Medicine & Life Sciences